These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 3279179

  • 1. Neutral endopeptidase and angiotensin converting enzyme inhibitors potentiate kinin-induced contraction of ferret trachea.
    Dusser DJ, Nadel JA, Sekizawa K, Graf PD, Borson DB.
    J Pharmacol Exp Ther; 1988 Feb; 244(2):531-6. PubMed ID: 3279179
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat.
    Sulpizio AC, Pullen MA, Edwards RM, Brooks DP.
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1141-7. PubMed ID: 14769834
    [Abstract] [Full Text] [Related]

  • 5. Role of ACE and NEP in bradykinin-induced relaxation and contraction response of isolated porcine basilar artery.
    Miyamoto A, Murata S, Nishio A.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):365-70. PubMed ID: 12012022
    [Abstract] [Full Text] [Related]

  • 6. Kinin-mediated coronary nitric oxide production contributes to the therapeutic action of angiotensin-converting enzyme and neutral endopeptidase inhibitors and amlodipine in the treatment in heart failure.
    Zhang X, Recchia FA, Bernstein R, Xu X, Nasjletti A, Hintze TH.
    J Pharmacol Exp Ther; 1999 Feb; 288(2):742-51. PubMed ID: 9918584
    [Abstract] [Full Text] [Related]

  • 7. Enkephalinase inhibitor potentiates substance P- and electrically induced contraction in ferret trachea.
    Sekizawa K, Tamaoki J, Nadel JA, Borson DB.
    J Appl Physiol (1985); 1987 Oct; 63(4):1401-5. PubMed ID: 2447055
    [Abstract] [Full Text] [Related]

  • 8. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
    Duncan AM, James GM, Anastasopoulos F, Kladis A, Briscoe TA, Campbell DJ.
    J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017
    [Abstract] [Full Text] [Related]

  • 9. Marked difference between angiotensin-converting enzyme and neutral endopeptidase inhibition in vivo by a dual inhibitor of both enzymes.
    Anastasopoulos F, Leung R, Kladis A, James GM, Briscoe TA, Gorski TP, Campbell DJ.
    J Pharmacol Exp Ther; 1998 Mar; 284(3):799-805. PubMed ID: 9495836
    [Abstract] [Full Text] [Related]

  • 10. Neutral endopeptidase up-regulation in isolated human umbilical artery: involvement in desensitization of bradykinin-induced vasoconstrictor effects.
    Pelorosso FG, Halperin AV, Palma AM, Nowak W, Errasti AE, Rothlin RP.
    J Pharmacol Exp Ther; 2007 Feb; 320(2):713-20. PubMed ID: 17085545
    [Abstract] [Full Text] [Related]

  • 11. Pharmacologic studies on the differential influence of inhibitors of neutral endopeptidase on nonadrenergic, noncholinergic contractile responses of the guinea pig isolated hilar bronchus to transmural electrical stimulation and exogenously applied tachykinins.
    Warner EA, Krell RD, Buckner CK.
    J Pharmacol Exp Ther; 1990 Sep; 254(3):824-30. PubMed ID: 2395113
    [Abstract] [Full Text] [Related]

  • 12. Enkephalinase inhibitor potentiates substance P- and capsaicin-induced bronchial smooth muscle contractions in humans.
    Honda I, Kohrogi H, Yamaguchi T, Ando M, Araki S.
    Am Rev Respir Dis; 1991 Jun; 143(6):1416-8. PubMed ID: 1710881
    [Abstract] [Full Text] [Related]

  • 13. Neutral endopeptidase inhibitors potentiate substance P-induced contraction in gut smooth muscle.
    Djokic TD, Sekizawa K, Borson DB, Nadel JA.
    Am J Physiol; 1989 Jan; 256(1 Pt 1):G39-43. PubMed ID: 2463769
    [Abstract] [Full Text] [Related]

  • 14. Endothelial angiotensin-converting enzyme and neutral endopeptidase in isolated human umbilical vein: an effective bradykinin inactivation pathway.
    Nowak W, Errasti AE, Armesto AR, Santín Velazque NL, Rothlin RP.
    Eur J Pharmacol; 2011 Sep 30; 667(1-3):271-7. PubMed ID: 21651905
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin-converting enzyme and neutral endopeptidase modulate smokeless tobacco-induced increase in macromolecular efflux from the oral mucosa in vivo.
    Gao XP, Suzuki H, Olopade CO, Pakhlevaniants S, Rubinstein I.
    J Lab Clin Med; 1997 Oct 30; 130(4):395-400. PubMed ID: 9358078
    [Abstract] [Full Text] [Related]

  • 16. Neutral endopeptidase and angiotensin-converting enzyme inhibitors increase nitric oxide production in isolated canine coronary microvessels by a kinin-dependent mechanism.
    Zhang X, Nasjletti A, Xu X, Hintze TH.
    J Cardiovasc Pharmacol; 1998 Apr 30; 31(4):623-9. PubMed ID: 9554814
    [Abstract] [Full Text] [Related]

  • 17. Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs.
    Seymour AA, Sheldon JH, Smith PL, Asaad M, Rogers WL.
    J Pharmacol Exp Ther; 1994 Apr 30; 269(1):263-70. PubMed ID: 8169834
    [Abstract] [Full Text] [Related]

  • 18. Effects of bradykinin receptor agonists, and captopril and thiorphan in ferret isolated trachea: evidence for bradykinin generation in vitro.
    Farmer SG, Broom T, DeSiato MA.
    Eur J Pharmacol; 1994 Jul 11; 259(3):309-13. PubMed ID: 7982459
    [Abstract] [Full Text] [Related]

  • 19. Effects of neutral endopeptidase (neprilysin) inhibition on the response to other vasoactive peptides in small human resistance arteries: studies with thiorphan and omapatrilat.
    Dalzell JR, Seed A, Berry C, Whelan CJ, Petrie MC, Padmanabhan N, Clarke A, Biggerstaff F, Hillier C, McMurray JJ.
    Cardiovasc Ther; 2014 Feb 11; 32(1):13-8. PubMed ID: 24138103
    [Abstract] [Full Text] [Related]

  • 20. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
    Campbell DJ, Anastasopoulos F, Duncan AM, James GM, Kladis A, Briscoe TA.
    J Pharmacol Exp Ther; 1998 Nov 11; 287(2):567-77. PubMed ID: 9808682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.